SHENYANG XINGQI PHARMACEUTICAL CO.(SZ:300573) Zheng Quan Shi Bao Wang·2025-12-07 08:31Core Viewpoint - The company Xingqi Eye Medicine (300573) announced that 39 of its products will continue to be included in the 2025 National Medical Insurance Catalog, with no products being removed from the catalog [1] Group 1 - The company has 39 products included in the 2025 National Medical Insurance Catalog, consisting of 8 Class A and 31 Class B products [1] - Specific products such as Cyclosporine Eye Drops (II), Compound Electrolyte Eye Irrigation Solution, and Sodium Hyaluronate Eye Drops will continue to be covered [1] - The statement regarding the use of Gatifloxacin Eye Gel as a "second-line medication" has been removed from the catalog notes [1] Group 2 - The inclusion status of the company's other products in the 2025 National Medical Insurance Catalog remains unchanged from the 2024 catalog [1]